share_log

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-CHIEF FINANCIAL OFFICER Dais Craig

SEC ·  Nov 15, 2023 05:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more